Prot# 718-CNP-202: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Parkinson's Disease Cognitive Impairment

Project: Research project

Project Details

StatusActive
Effective start/end date2/28/232/28/26

Funding

  • Parexel (Prot# 718-CNP-202 // Prot# 718-CNP-202)
  • Sage Therapeutics, Inc. (Prot# 718-CNP-202 // Prot# 718-CNP-202)